Thanks to clinical trial research, more people with mesothelioma are living longer and enjoying better quality of life. Researchers hope to soon discover a combination of drugs and therapies to effectively manage mesothelioma and keep it under control. 

This year, the European Cystic Fibrosis Society’s Clinical Trial Network (ECFS-CTN) celebrates its fifth anniversary. To celebrate this milestone, it seemed appropriate to highlight the excellent work this network is doing in facilitating high-quality, efficient clinical trials for cystic fibrosis (CF) treatments. One of the key reasons for this network’s success is its strong emphasis on the involvement of patient organisations in clinical research.

According to a national public opinion poll commissioned by Research!America, which was published in June 2013, more than two thirds (72%) of Americans says it is likely they would participate in a clinical trial if recommended by their doctor, while only 22% can recall a health care professional ever talking to them about medical research. The results of this survey clearly point to the need for improved education about the importance and benefits of clinical trials.

Clinical trials are key to moving medicine forward as they look at new ways to prevent, detect or treat disease, in the form of new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment or a novel way to use an existing treatment works and is safe.

Subscribe to RSS - Clinical Trials